Medicure (MCUJF) Non-Current Deferred Tax Liability (2016 - 2017)

Medicure's (MCUJF) quarterly Non-Current Deferred Tax Liability came in at $478968.2 in Q4 2017, down 98.33% year-on-year from $28.6 million in Q4 2016, and down 98.14% quarter-over-quarter from $25.8 million in Q3 2017.

Medicure (MCUJF) Non-Current Deferred Tax Liability (2016 - 2017) Analysis & Trends

Medicure's Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $478968.2 for Q4 2017.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 98.33% year-over-year to $478968.2 in Q4 2017; TTM through Dec 2017 was $478968.2, a 98.33% decrease from a year earlier, with the FY2017 full-year figure at $469025.3, down 98.36% from the prior year.
  • Non-Current Deferred Tax Liability retreated to $478968.2 in Q4 2017 per MCUJF's latest filing, from $25.8 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $28.6 million in Q4 2016 and bottomed at $478968.2 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Medicure 8.77 Mn 7.64 Mn 2.57 Mn

Historic Data

Download Data
DateValue
Dec 31, 2017 478,968.19
Dec 31, 2017 478,968.19
Sep 30, 2017 25.78 Mn
Sep 30, 2017 25.78 Mn
Jun 30, 2017 26.45 Mn
Jun 30, 2017 26.45 Mn
Mar 31, 2017 27.06 Mn
Mar 31, 2017 27.06 Mn
Dec 31, 2016 28.60 Mn
Dec 31, 2016 28.60 Mn